bufalin has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Ni, W; Qian, C; Rong, X; Sun, L; Wang, J; Wen, J | 1 |
| Huang, W; Huang, Y; Jia, Q; Lin, W; Wen, L; Xie, X; Yin, J; Zeng, W | 1 |
2 other study(ies) available for bufalin and Innate Inflammatory Response
| Article | Year |
|---|---|
Bufalin, a bioactive component of the Chinese medicine chansu, inhibits inflammation and invasion of human rheumatoid arthritis fibroblast-like synoviocytes.
Topics: Arthritis, Rheumatoid; Bufanolides; Cartilage; Cell Nucleus; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Interleukin-8; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; NF-kappa B; Synovial Fluid; Tumor Necrosis Factor-alpha | 2014 |
Anti-inflammatory and antinociceptive activities of bufalin in rodents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Bufanolides; Carrageenan; Cyclooxygenase 2; Edema; Inflammation; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; Pain; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2014 |